Actively Recruiting

Age: 18Years +
All Genders
ID07512505

Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor

Led by Our Lady's Hospice and Care Services · Updated on 2026-04-06

120

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use of remote monitoring of vital signs through commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care. The study aims to see if this monitoring can help identify infections or other reversible problems earlier, improve estimates of how long a person has to live, and understand the relationship between pain or other symptoms and vital signs. Participants will wear a small, flexible, patch-like ECG device attached to the chest with an adhesive patch during their time in the hospice. The device's battery will be changed every 14 days by the research team, who will also check the device remotely to ensure it is working properly. The device will be worn until the patient dies, withdraws from the study, is discharged, or improves sufficiently to no longer require end-of-life care. During the study, researchers will collect information from medical notes and drug charts and will monitor the device's data remotely. The nursing team will check the patch daily to ensure it stays attached. Outcome measures include heart rate variability, heart rate, respiratory rate, and skin temperature at specific times before death, as well as the occurrence of clinical events like increased medication use or infections. Participation lasts up to 14 days or until the patient's hospice stay ends.

CONDITIONS

Brief Title

Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Primary diagnosis of malignant disease
  • Admitted for end-of-life care or focus of care changed to end-of-life care
  • Estimated prognosis less than 14 days
Not Eligible

You will not qualify if you...

  • Primary diagnosis of non-malignant disease
  • Unable to provide informed consent
  • Contraindications to using biosensor adhesive patch, such as chest wall skin problems or allergy to adhesive

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) for consent and eligibility assessment

Monitoring

Duration - Up to 14 days or until death, withdrawal, discharge, or clinical improvement

Participants wear a small, flexible ECG monitoring device continuously during their time in the hospice. The research team remotely checks the device and replaces it every 14 days as needed. Nursing staff check the adhesive patch daily.

Initial device application visit, 1 visit after 24 hours, and multiple visits a couple of times per week

Trial Site Locations

Total: 1 location

1

Our Lady's Hospice and Care Services

Dublin, Ireland

Actively Recruiting

Loading map...

Research Team

H

Hailey Goffinet, MSN

P

Professor Andrew Davies

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial